Balance Sheet Okamura Corporation

Equities

7994

JP3192400004

Business Support Supplies

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-05-19 am EDT			5-day change	1st Jan Change
2,370.00 ^JPY	+2.20%		+1.89%	+3.36%

May. 11	Okamura Corporation Provides Consolidated Earnings Guidance for the First Half and Full Fiscal Year Ending March 31, 2027	CI
May. 11	Okamura Corporation Proposes Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 25, 2026; Provides Dividend Guidance for the Second Quarter-End and Full Fiscal Year Ending March 31, 2027	CI

0.wOVvRPb5f65y8-QJzB6hDBMtHt8Oqq7_mrDnbr8MF64.i9EeNrKWCvE4pKk4kyzpQ1lILJZfnt6cw97WP8c7fcqu0xhzoJw-xCuhtQ

Published financial data: OKAMURA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	244B	261B	277B	298B	315B
Total Revenues	244B	261B	277B	298B	315B
Cost of Goods Sold, Total	164B	178B	188B	199B	209B
Gross Profit	80.11B	83.59B	89B	99.77B	106B
Selling General & Admin Expenses, Total	63.54B	65.43B	69.26B	73.39B	79.28B
Depreciation & Amortization - (IS)	2.4B	2.18B	2.37B	2.35B	2.32B
Other Operating Expenses, Total	65.94B	67.61B	71.63B	75.74B	81.59B
Operating Income	14.18B	15.97B	17.37B	24.04B	23.94B
Interest Expense, Total	-163M	-151M	-180M	-153M	-303M
Interest And Investment Income	907M	888M	926M	1.01B	1.06B
Net Interest Expenses	744M	737M	746M	855M	758M
Income (Loss) On Equity Invest.	193M	395M	469M	510M	1.4B
Currency Exchange Gains (Loss)	-	374M	339M	182M	14M
Other Non Operating Income (Expenses)	543M	293M	379M	813M	524M
EBT, Excl. Unusual Items	15.66B	17.77B	19.31B	26.4B	26.63B
Gain (Loss) On Sale Of Investments	2.34B	3.9B	4.34B	3.37B	4.04B
Gain (Loss) On Sale Of Assets	154M	-283M	-382M	-171M	-173M
Asset Writedown	-41M	-76M	-143M	-35M	-14M
Other Unusual Items	-102M	357M	24M	-1M	-1M
EBT, Incl. Unusual Items	18.01B	21.67B	23.15B	29.56B	30.48B
Income Tax Expense	6.06B	6.59B	6.94B	8.93B	8.4B
Earnings From Continuing Operations	11.95B	15.07B	16.21B	20.63B	22.08B
Net Income to Company	11.95B	15.07B	16.21B	20.63B	22.08B
Minority Interest	21M	-82M	-307M	-348M	-36M
Net Income - (IS)	11.97B	14.99B	15.91B	20.28B	22.04B
Net Income to Common Incl Extra Items	11.97B	14.99B	15.91B	20.28B	22.04B
Net Income to Common Excl. Extra Items	11.97B	14.99B	15.91B	20.28B	22.04B
Per Share Items
Net EPS - Basic	112.5	151.25	163.14	214.27	232.94
Basic EPS - Continuing Operations	112.5	151.25	163.14	214.27	232.94
Basic Weighted Average Shares Outstanding	106M	99.12M	97.5M	94.65M	94.64M
Net EPS - Diluted	112.5	151.25	163.14	214.27	232.94
Diluted EPS - Continuing Operations	112.5	151.25	163.14	214.27	232.94
Diluted Weighted Average Shares Outstanding	106M	99.12M	97.5M	94.65M	94.64M
Normalized Basic EPS	92.16	111.23	120.61	170.64	175.5
Normalized Diluted EPS	92.16	111.23	120.61	170.64	175.5
Dividend Per Share	32	40	55	86	94
Payout Ratio	25.8	26.63	25.85	35.47	37.82
Supplemental Items
EBITDA	20.18B	21.71B	23.59B	30.57B	30.73B
EBITA	14.18B	15.97B	17.37B	24.04B	23.94B
EBIT	14.18B	15.97B	17.37B	24.04B	23.94B
EBITDAR	28.94B	29.57B	32.64B	39.46B	39.4B
Effective Tax Rate - (Ratio)	33.64	30.43	29.96	30.21	27.55
Normalized Net Income	9.81B	11.03B	11.76B	16.15B	16.61B
Non-Cash Pension Expense	-33M	81M	237M	-195M	-69M
Supplemental Operating Expense Items
Selling and Marketing Expenses	12.39B	12.42B	12.12B	12.9B	13.75B
Research And Development Expense From Footnotes	1.23B	1.26B	1.12B	1.49B	1.43B
Net Rental Expense, Total	8.76B	7.86B	9.06B	8.89B	8.67B
Imputed Operating Lease Interest Expense	521M	439M	610M	518M	742M
Imputed Operating Lease Depreciation	8.24B	7.43B	8.45B	8.37B	7.93B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	45.16B	39.95B	38.53B	39.17B	26.24B
Short Term Investments	10M	-	491M	-	-
Total Cash And Short Term Investments	45.17B	39.95B	39.02B	39.17B	26.24B
Accounts Receivable, Total	66.81B	68.77B	73.41B	81.26B	87.62B
Total Receivables	66.81B	68.77B	73.41B	81.26B	87.62B
Inventory	14.8B	20.65B	21.16B	21.35B	22.21B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	2.54B	2.64B	3.84B	3.21B	3.54B
Total Current Assets	129B	132B	137B	145B	140B
Net Property Plant And Equipment	58.24B	59.52B	66.35B	76.77B	86.86B
Long-term Investments	54.35B	48.08B	43.68B	54.08B	51.36B
Goodwill	-	2.41B	2.16B	2.53B	5.98B
Other Intangibles, Total	3.38B	3.14B	3.05B	3.38B	4.91B
Deferred Tax Assets Long-Term	184M	216M	222M	366M	421M
Other Long-Term Assets, Total	2M	3M	2M	2M	2M
Total Assets	245B	245B	253B	282B	289B
Liabilities
Accounts Payable, Total	44.86B	40.54B	40.51B	42.87B	28.23B
Accrued Expenses, Total	3.93B	4.36B	4.25B	6.24B	4.44B
Short-term Borrowings	6.11B	6.07B	6.31B	6.19B	6.17B
Current Portion of Long-Term Debt	1.67B	5.69B	1.19B	5.2B	1.85B
Current Income Taxes Payable	6.72B	6.5B	6.15B	8.44B	6.09B
Other Current Liabilities	5.68B	7.11B	8.06B	7.35B	6.94B
Total Current Liabilities	68.97B	70.27B	66.47B	76.29B	53.72B
Long-Term Debt	13.94B	9.83B	13.65B	9.47B	27.82B
Pension & Other Post Retirement Benefits	15.91B	15.94B	15.17B	14.31B	13.04B
Deferred Tax Liability Non Current	2.74B	887M	727M	3.26B	3.42B
Other Non Current Liabilities	4.14B	4.32B	4.2B	4B	4.35B
Total Liabilities	106B	101B	100B	107B	102B
Common Stock, Total	18.67B	18.67B	18.67B	18.67B	18.67B
Additional Paid In Capital	16.77B	16.77B	16.77B	16.77B	16.77B
Retained Earnings	90.24B	100B	112B	125B	139B
Treasury Stock	-110M	-3.63B	-7.71B	-7.72B	-7.73B
Comprehensive Income and Other	13.19B	10.46B	10.86B	19.4B	18.5B
Total Common Equity	139B	143B	151B	172B	185B
Minority Interest	1.02B	1.49B	1.95B	2.44B	1.65B
Total Equity	140B	144B	153B	175B	187B
Total Liabilities And Equity	245B	245B	253B	282B	289B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	100M	97.74M	94.65M	94.64M	94.64M
ECS Total Common Shares Outstanding	100M	97.74M	94.65M	94.64M	94.64M
Book Value / Share	1.38K	1.46K	1.59K	1.82K	1.96K
Tangible Book Value	135B	137B	146B	166B	174B
Tangible Book Value Per Share	1.35K	1.4K	1.54K	1.76K	1.84K
Total Debt	21.72B	21.59B	21.16B	20.86B	35.84B
Net Debt	-23.45B	-18.36B	-17.87B	-18.31B	9.59B
Debt Equivalent of Unfunded Proj. Benefit Obligation	14.98B	14.96B	14.24B	13.12B	11.83B
Debt Equivalent Oper. Leases	70.09B	62.91B	72.45B	71.11B	69.38B
Minority Interest, Total (Incl. Fin. Div)	1.02B	1.49B	1.95B	2.44B	1.65B
Inventories - Raw Materials, Total	4.47B	5.1B	5.89B	6.25B	6.76B
Inventories - Work In Process, Total	1.51B	5.83B	5.3B	6.49B	6.98B
Inventories - Finished Goods, Total	8.82B	9.72B	9.97B	8.6B	8.47B
Full Time Employees	5.2K	5.41K	5.49K	5.49K	4.16K
Accumulated Allowance for Doubtful Accounts (Supple)	27M	155M	157M	173M	241M
Order Backlog	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	18.01B	21.67B	23.15B	29.56B	30.48B
Depreciation & Amortization - CF	6B	5.74B	6.21B	6.53B	6.79B
Depreciation & Amortization, Total	6B	5.74B	6.21B	6.53B	6.79B
(Gain) Loss From Sale Of Asset	-112M	353M	515M	202M	174M
(Gain) Loss on Sale of Investments - (CF)	-2.34B	-3.9B	-4.34B	-3.37B	-4.04B
(Income) Loss On Equity Investments - (CF)	-193M	-395M	-469M	-510M	-1.4B
Other Operating Activities, Total	-4.32B	-5.04B	-8.14B	-8.1B	-9.5B
Change In Accounts Receivable	4.75B	-4.79B	-4.6B	-7.86B	-6.43B
Change In Inventories	3.33B	-3.27B	-498M	-184M	-866M
Change In Accounts Payable	1.85B	-6.79B	469M	2.66B	-13.96B
Change in Other Net Operating Assets	-51M	1.74B	1.19B	2.41B	-268M
Cash from Operations	26.92B	5.33B	13.49B	21.35B	983M
Capital Expenditure	-4.74B	-5.24B	-12.37B	-15.77B	-16.46B
Sale of Property, Plant, and Equipment	651M	329M	278M	263M	434M
Cash Acquisitions	-	-2.46B	-	-	-
Sale (Purchase) of Intangible assets	-1.03B	-820M	-1.01B	-1.29B	-2.37B
Investment in Marketable and Equity Securities, Total	4.09B	5.67B	6.45B	4.13B	4.49B
Other Investing Activities, Total	201M	255M	-6M	414M	-367M
Cash from Investing	-833M	-2.26B	-6.66B	-12.25B	-14.27B
Short Term Debt Issued, Total	-	-	212M	-	-
Long-Term Debt Issued, Total	2.11B	1.3B	5.3B	1.02B	20.2B
Total Debt Issued	2.11B	1.3B	5.51B	1.02B	20.2B
Short Term Debt Repaid, Total	-131M	-87M	-	-165M	-53M
Long-Term Debt Repaid, Total	-2.39B	-1.7B	-6.02B	-1.19B	-5.2B
Total Debt Repaid	-2.52B	-1.79B	-6.02B	-1.36B	-5.25B
Repurchase of Common Stock	-8.83B	-3.53B	-4.07B	-1M	-1M
Common Dividends Paid	-3.09B	-3.99B	-4.11B	-7.19B	-8.34B
Common & Preferred Stock Dividends Paid	-3.09B	-3.99B	-4.11B	-7.19B	-8.34B
Other Financing Activities, Total	-742M	-592M	-794M	-666M	-6.82B
Cash from Financing	-13.07B	-8.6B	-9.48B	-8.2B	-209M
Foreign Exchange Rate Adjustments	-91M	305M	406M	313M	691M
Miscellaneous Cash Flow Adjustments	-3M	-	61M	-	-
Net Change in Cash	12.92B	-5.23B	-2.19B	1.22B	-12.8B
Supplemental Items
Cash Interest Paid	163M	156M	182M	152M	284M
Cash Income Tax Paid (Refund)	4.27B	6.18B	7.58B	8.22B	9.7B
Levered Free Cash Flow	19.11B	-1.02B	-2.33B	2.94B	-24.02B
Unlevered Free Cash Flow	19.21B	-924M	-2.22B	3.03B	-23.83B
Change In Net Working Capital	-10.12B	10.59B	5.91B	1.46B	26.75B
Net Debt Issued / Repaid	-414M	-490M	-510M	-339M	14.95B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.68	4.07	4.36	5.62	5.24
Return on Total Capital	5.55	6.1	6.4	8.13	7.15
Return On Equity %	8.68	10.62	10.92	12.6	12.21
Return on Common Equity	8.77	10.66	10.84	12.55	12.33
Margin Analysis
Gross Profit Margin %	32.77	32	32.13	33.45	33.55
SG&A Margin	25.99	25.05	25	24.6	25.21
EBITDA Margin %	8.26	8.31	8.51	10.25	9.77
EBITA Margin %	5.8	6.12	6.27	8.06	7.61
EBIT Margin %	5.8	6.12	6.27	8.06	7.61
Income From Continuing Operations Margin %	4.89	5.77	5.85	6.92	7.02
Net Income Margin %	4.9	5.74	5.74	6.8	7.01
Net Avail. For Common Margin %	4.9	5.74	5.74	6.8	7.01
Normalized Net Income Margin	4.01	4.22	4.24	5.41	5.28
Levered Free Cash Flow Margin	7.82	-0.39	-0.84	0.99	-7.64
Unlevered Free Cash Flow Margin	7.86	-0.35	-0.8	1.02	-7.58
Asset Turnover
Asset Turnover	1.01	1.06	1.11	1.12	1.1
Fixed Assets Turnover	4.2	4.44	4.4	4.17	3.84
Receivables Turnover (Average Receivables)	3.53	3.85	3.9	3.86	3.72
Inventory Turnover (Average Inventory)	9.98	10.02	8.99	9.34	9.6
Short Term Liquidity
Current Ratio	1.87	1.88	2.07	1.9	2.6
Quick Ratio	1.62	1.55	1.69	1.58	2.12
Operating Cash Flow to Current Liabilities	0.39	0.08	0.2	0.28	0.02
Days Sales Outstanding (Average Receivables)	103.29	94.74	93.67	94.89	97.99
Days Outstanding Inventory (Average Inventory)	36.57	36.43	40.59	39.19	38.04
Average Days Payable Outstanding	99.78	84.97	78.46	76.79	61.83
Cash Conversion Cycle (Average Days)	40.08	46.19	55.8	57.29	74.2
Long Term Solvency
Total Debt/Equity	15.54	14.98	13.86	11.93	19.19
Total Debt / Total Capital	13.45	13.03	12.17	10.66	16.1
LT Debt/Equity	9.97	6.82	8.94	5.42	14.89
Long-Term Debt / Total Capital	8.63	5.93	7.85	4.84	12.49
Total Liabilities / Total Assets	43.06	41.26	39.62	38.04	35.4
EBIT / Interest Expense	86.97	105.78	96.52	157.11	79
EBITDA / Interest Expense	123.81	143.77	131.03	199.8	101.41
(EBITDA - Capex) / Interest Expense	94.71	109.09	62.32	96.75	47.09
Total Debt / EBITDA	1.08	0.99	0.9	0.68	1.17
Net Debt / EBITDA	-1.16	-0.85	-0.76	-0.6	0.31
Total Debt / (EBITDA - Capex)	1.41	1.31	1.89	1.41	2.51
Net Debt / (EBITDA - Capex)	-1.52	-1.11	-1.59	-1.24	0.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.44	6.84	6.06	7.68	5.44
Gross Profit, 1 Yr. Growth %	-2	4.34	6.48	12.1	5.77
EBITDA, 1 Yr. Growth %	4.43	7.58	8.64	29.61	0.51
EBITA, 1 Yr. Growth %	5.86	12.68	8.76	38.36	-0.42
EBIT, 1 Yr. Growth %	5.86	12.68	8.76	38.36	-0.42
Earnings From Cont. Operations, 1 Yr. Growth %	20.93	26.14	7.56	27.23	7.04
Net Income, 1 Yr. Growth %	21.52	25.24	6.1	27.5	8.7
Normalized Net Income, 1 Yr. Growth %	6.32	12.44	6.66	37.34	2.84
Diluted EPS Before Extra, 1 Yr. Growth %	25.79	34.44	7.86	31.34	8.71
Accounts Receivable, 1 Yr. Growth %	-6.63	2.94	6.75	10.69	7.83
Inventory, 1 Yr. Growth %	-18.41	39.54	2.5	0.86	4.05
Net Property, Plant and Equip., 1 Yr. Growth %	0.25	2.18	11.48	15.7	13.14
Total Assets, 1 Yr. Growth %	3.87	-0.04	3.07	11.55	2.49
Tangible Book Value, 1 Yr. Growth %	3.72	1.26	6.17	14.36	4.7
Common Equity, 1 Yr. Growth %	3.33	2.79	5.7	14.33	7.42
Cash From Operations, 1 Yr. Growth %	85.65	-80.21	153.21	58.26	-95.4
Capital Expenditures, 1 Yr. Growth %	-6.65	10.42	136.18	27.48	4.38
Levered Free Cash Flow, 1 Yr. Growth %	201.18	-105.33	129.06	-226.01	-917.21
Unlevered Free Cash Flow, 1 Yr. Growth %	198	-104.81	140.28	-236.71	-885.22
Dividend Per Share, 1 Yr. Growth %	0	25	37.5	56.36	9.3
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.7	1.57	6.45	6.87	6.56
Gross Profit, 2 Yr. CAGR %	0.75	1.12	5.4	9.25	8.89
EBITDA, 2 Yr. CAGR %	6.01	5.99	8.11	18.66	14.14
EBITA, 2 Yr. CAGR %	6.84	9.22	10.7	22.67	17.38
EBIT, 2 Yr. CAGR %	6.84	9.22	10.7	22.67	17.38
Earnings From Cont. Operations, 2 Yr. CAGR %	8	23.51	16.48	16.98	16.7
Net Income, 2 Yr. CAGR %	8.15	23.36	15.27	16.31	17.73
Normalized Net Income, 2 Yr. CAGR %	6.37	9.34	9.51	21.03	18.85
Diluted EPS Before Extra, 2 Yr. CAGR %	10.04	30.04	20.42	19.02	19.49
Accounts Receivable, 2 Yr. CAGR %	1.49	-1.96	4.83	8.7	9.25
Inventory, 2 Yr. CAGR %	-12.01	6.7	19.59	1.68	2.45
Net Property, Plant and Equip., 2 Yr. CAGR %	0.93	1.21	6.73	13.57	14.41
Total Assets, 2 Yr. CAGR %	3.47	1.9	1.5	7.23	6.92
Tangible Book Value, 2 Yr. CAGR %	3.67	2.48	3.69	10.19	9.42
Common Equity, 2 Yr. CAGR %	3.34	3.06	4.23	9.93	10.82
Cash From Operations, 2 Yr. CAGR %	68.66	-39.38	-29.21	100.18	-73.01
Capital Expenditures, 2 Yr. CAGR %	-6.51	1.52	61.49	73.52	15.35
Levered Free Cash Flow, 2 Yr. CAGR %	145.15	-59.94	-65.07	69.9	220.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	141.66	-62.15	-66.01	81.24	227.64
Dividend Per Share, 2 Yr. CAGR %	6.9	11.8	31.1	46.63	30.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.37	1.75	3.05	6.86	6.39
Gross Profit, 3 Yr. CAGR %	1.86	1.93	2.88	7.59	8.08
EBITDA, 3 Yr. CAGR %	2.85	6.53	6.87	14.85	12.27
EBITA, 3 Yr. CAGR %	2.55	8.75	9.07	19.25	14.44
EBIT, 3 Yr. CAGR %	2.55	8.75	9.07	19.25	14.44
Earnings From Cont. Operations, 3 Yr. CAGR %	3.23	13.74	17.94	19.96	13.57
Net Income, 3 Yr. CAGR %	3.43	13.57	17.32	19.21	13.71
Normalized Net Income, 3 Yr. CAGR %	3.76	8.35	8.44	18.1	14.63
Diluted EPS Before Extra, 3 Yr. CAGR %	4.63	17.64	22.18	23.96	15.48
Accounts Receivable, 3 Yr. CAGR %	-0.56	1.97	0.86	6.75	8.41
Inventory, 3 Yr. CAGR %	-5.8	2.61	5.28	12.99	2.46
Net Property, Plant and Equip., 3 Yr. CAGR %	1.11	1.35	4.53	9.64	13.43
Total Assets, 3 Yr. CAGR %	1.35	2.29	2.29	4.75	5.62
Tangible Book Value, 3 Yr. CAGR %	3.76	2.86	3.7	7.13	8.33
Common Equity, 3 Yr. CAGR %	3.48	3.16	3.93	7.5	9.08
Cash From Operations, 3 Yr. CAGR %	30.7	-17.43	-2.38	-7.44	-43.07
Capital Expenditures, 3 Yr. CAGR %	3.8	-1.17	34.52	49.25	46.48
Levered Free Cash Flow, 3 Yr. CAGR %	40.58	-31.59	-28.37	-46.42	186.79
Unlevered Free Cash Flow, 3 Yr. CAGR %	40	-34.51	-29.91	-45.94	195.46
Dividend Per Share, 3 Yr. CAGR %	7.17	12.62	19.79	39.03	32.95
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.3	1.98	2.76	3.77	4.44
Gross Profit, 5 Yr. CAGR %	1.74	2.47	3.27	4.8	5.24
EBITDA, 5 Yr. CAGR %	3.31	4.92	4.92	11.23	9.72
EBITA, 5 Yr. CAGR %	1.81	6.21	5.74	14.12	12.32
EBIT, 5 Yr. CAGR %	1.81	6.21	5.74	14.12	12.32
Earnings From Cont. Operations, 5 Yr. CAGR %	5.57	12.48	8.34	15.02	17.45
Net Income, 5 Yr. CAGR %	5.71	12.57	8.01	14.66	17.48
Normalized Net Income, 5 Yr. CAGR %	2.93	6.7	6.02	13.26	12.49
Diluted EPS Before Extra, 5 Yr. CAGR %	6.45	14.97	10.68	18.19	21.1
Accounts Receivable, 5 Yr. CAGR %	0.2	1.31	1.56	4.61	4.13
Inventory, 5 Yr. CAGR %	-0.42	5.28	3.64	2.24	4.14
Net Property, Plant and Equip., 5 Yr. CAGR %	2.55	1.13	3.32	6.07	8.38
Total Assets, 5 Yr. CAGR %	2.45	2.32	1.41	4.24	4.12
Tangible Book Value, 5 Yr. CAGR %	5.68	4.66	3.73	5.73	5.95
Common Equity, 5 Yr. CAGR %	5.14	4.64	3.78	5.81	6.63
Cash From Operations, 5 Yr. CAGR %	14.18	-14.17	2.27	17.67	-41.62
Capital Expenditures, 5 Yr. CAGR %	1.4	-10.6	23.87	23.78	26.5
Levered Free Cash Flow, 5 Yr. CAGR %	25.09	20.9	-19.45	-1.56	30.5
Unlevered Free Cash Flow, 5 Yr. CAGR %	24.49	10.78	-20.53	-1.6	29.88
Dividend Per Share, 5 Yr. CAGR %	9.86	10.76	16.17	25.16	24.05